Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis

CONTEXT: Kang-ai injection (KAI) is an authorized herbal medicine used in cancer treatment. However, its clinical efficacy in hepatocellular carcinoma (HCC) has not been investigated thoroughly. OBJECTIVE: To systematically evaluate the efficacy and safety of KAI in patients with HCC. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chuihua, Dong, Fang, Xiao, Ting, Gao, Wenni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081330/
https://www.ncbi.nlm.nih.gov/pubmed/33905666
http://dx.doi.org/10.1080/13880209.2021.1915340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081330/
https://www.ncbi.nlm.nih.gov/pubmed/33905666
http://dx.doi.org/10.1080/13880209.2021.1915340

Ejemplares similares